Research & development decreased 22.5%
Research & development changed -22.5% from the comparable as-filed period.
$467,297→$362,1653 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FCUV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue moved 37907 bp lower
Inventory / revenue changed -37907 basis points from the comparable as-filed period.
391.65%→12.58%3 prior comparisons
Inventory decreased 38.6%
Inventory changed -38.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$138,370→$84,9504 prior comparisons
Current ratio increased 31.8%
Current ratio changed +31.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.85→2.444 prior comparisons
Receivables / revenue moved 974 bp higher
Receivables / revenue changed +974 basis points from the comparable as-filed period.
0.42%→10.17%3 prior comparisons
Operating income decreased 0.4%
Operating income changed -0.4% from the comparable as-filed period.
-$1.5M→-$1.5M3 prior comparisons
Net income decreased 0.9%
Net income changed -0.9% from the comparable as-filed period.
-$1.5M→-$1.5M3 prior comparisons
Current liabilities increased 0.9%
Current liabilities changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$829,224→$836,4234 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.